Shares of Lilly rose as much as 1.7% on Friday, pushing its market value to about $1 trillion, according to data compiled by ...

In March, Trainor – who was once best known for her body positivity anthem “All About the Bass” – revealed that she lost 60 ...

The government is considering allowing global tenders for essential patented medicines, including treatments for obesity, ...

2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026? Eli Lilly is currently ...

Gemma Collins has revealed she had to stop taking weight-loss injections after suffering a "gallbladder attack" the could ...

A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss ...

As the market for weight management and anti-obesity grows rapidly in India, diagnostic players are hoping to cash in on the ...

US pharma giant Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1 trillion market valuation, a sharp turnaround from this summer when its stock was hit by disappointing ...

Gemma Collins has lost an impressive 31⁄2st since starting the weight-loss injections a year ago - but she was forced to stop taking them after suffering a "gallbladder attack" ...

Tan France opens up about 'Queer Eye's final season and his work with Zepbound, focusing on compassion, identity, and clothing without shame.

New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...